Jeffrey Berkowitz - Walgreens Boots President

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>WB</div>
WBA -- USA Stock  

 Earnings Call 

  President
Mr. Jeffrey Berkowitz J.D. serves as Executive Vice President of Walgreens Boots Alliance President of Pharma and Global Market Access of Walgreens Boots Alliance Inc. He is President of Pharma and Global Market Access and CoPresident of Walgreens Boots Alliance Development GmbH since January 2013. Prior to taking on this role Mr. Berkowitz served as the senior vice president Pharmaceutical Development and Market Access of Walgreens from September 2010 to January 2013. Prior to joining Walgreens Mr. Berkowitz served as senior vice president of global market access for Merck Company Inc. from November 2009 to September 2010. From 2002 to 2009 Mr. Berkowitz held a variety of positions with increasing responsibility in market access sales and marketing with ScheringPlough Corporationrationration prior to its acquisition by Merck in 2009. Mr. Berkowitz has served as a director of Infinity Pharmaceuticals Inc. a biopharmaceutical company since March 2014.
Age: 48        
847 315-2500  www.walgreensbootsalliance.com

Jeffrey Berkowitz Latest Insider Activity

Jeffrey Berkowitz over three months ago via Macroaxis 
Infinity Pharmaceuticals exotic insider transaction detected

Walgreens Boots Management Efficiency

Walgreens Boots Alli has Return on Asset of 7.0E-4 % which means that on every $100 spent on asset it made $7.0E-4 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.0014 % implying that it generated $0.0014 on every 100 dollars invested. Walgreens Boots management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Walgreens Boots Return on Investment is expected to slightly decrease based on the last few years of reporting. The last year's Return on Investment was at 10.78. The current year Return on Average Assets is expected to grow to 7.32, whereas Return on Average Equity is expected to decline to 14.17. Walgreens Boots Total Assets are expected to significantly increase based on the last few years of reporting. The last year's Total Assets were at 60.84 Billion. The current year Current Assets is expected to grow to about 25.9 B, whereas Revenue to Assets are expected to decline to 1.73. Walgreens Boots Liabilities Non Current is expected to significantly increase based on the last few years of reporting. The last year's Liabilities Non Current was at 22.85 Billion. The current year Tax Liabilities is expected to grow to about 2.8 B, whereas Total Liabilities is expected to decline to about 36.6 B.
The company has 17.93 B in debt with debt to equity (D/E) ratio of 74.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. Walgreens Boots Alli has Current Ratio of 0.72 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Brian ToddSysco
2017
Anne DamentTarget
2015
Jodeen KozlakTarget
2007
Casey CarlTarget
2014
Mary EdwardsSally Beauty Holdings
2019
Anu GuptaTarget
2015
Bryan EverettRite Aid
2019
R CharltonSysco
2015
Theodore FrumkinSprouts Farmers Market
2015
Doug DonleyRite Aid
2005
Anita ZielinskiSysco
2017
James ComitaleRite Aid
2015
Greg BertrandSysco
2018
Jocelyn KonradRite Aid
2019
Carrie McDermottSally Beauty Holdings
2006
Dave PrichardSpectrum Brands Holdings
N/A
Jeremy SmeltserSpectrum Brands Holdings
2019
Justin MennenRite Aid
2019
Mark SpinksSally Beauty Holdings
2015
Michael McNamaraTarget
2019
Laysha WardTarget
2017

Company Summary

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 232000 people.Walgreens Boots Alliance (WBA) is traded on BATS Exchange in USA and employs 232,000 people.

Walgreens Boots Alli Leadership Team

Alexander Gourlay, Executive VP and President of Walgreens Co
James Skinner, Executive Chairman
David Brailer, Independent Director
Leonard Schaeffer, Independent Director
Nancy Schlichting, Independent Director
Dominic Murphy, Director
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary
James Kehoe, Global CFO, Executive Vice President - Global
Anthony Roberts, Senior Vice President Global CIO
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer
John Lederer, Director
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands
Stefano Pessina, Executive Vice Chairman and CEO
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots
Gerald Gradwell, IR Contact Officer
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail
Barry Rosenstein, Independent Director
Jose Almeida, Director
Janice Babiak, Independent Director
William Foote, Lead Independent Director
Ginger Graham, Independent Director
George Fairweather, Global CFO and Executive VP

Stock Performance Indicators

Current Sentiment - WBA

Walgreens Boots Alli Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Walgreens Boots Alliance. What is your outlook on investing in Walgreens Boots Alliance? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>FOR</div>
Purchased over 500 shares of
few hours ago
Traded for 5.9
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>SON</div>
Purchased over 40 shares of
few hours ago
Traded for 66.75
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>AL</div>
Purchased few shares of
few hours ago
Traded for 1439.22
Check out Your Current Watchlist. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page